BioNTechCEOUğur Şahin and Pfizer CEO Albert Bourla both say that their vaccine is likely to be effective against severe disease resulting from the Omicron variant.
BioNTech CEO Uğur Şahin and Pfizer CEO Albert Bourla says that their vaccine is likely to be effective against severe disease from the Omicron variant.
BioNTech CEO Uğur Şahin and Pfizer CEO Albert Bourla bothsay that their vaccine is likely to be effective against severe diseaseresulting from the Omicron variant.